Molecular Diagnostics Market Share, Demand, Key Drivers, Players and Trend Analysis 2025

The Molecular Diagnostics Market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025. The global molecular diagnostics market is expected to reach USD 13.9 billion by 2025, from USD 7.1 billion in 2017 growing at a CAGR of 8.8% during the forecast period of 2018 to 2025. The clinical uses of molecular diagnostics can be found in no less than six colossal zones that are oncology, pharmacogenomics, human leukocyte antigen composing, irresistible ailments, hereditary illness screening and coagulation.

Get Free Sample PDF of This Research Report: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-molecular-diagnostics-market

The global molecular diagnostics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions and others to increase their footprints in this market. The report includes market shares of molecular diagnostics market for global, Europe, North America, Asia Pacific and South America. Some of the major players operating in the global molecular diagnostics market are

• Abbott Laboratories,
• Agilent Technologies,
• Becton,
• Dickinson and Company,
• Biomérieux Sa,
• Danaher Corporation,
• Diasorin,
• Grifols,
• Hologic Corporation,
• Qiagen,
• Myriad Genetics,
• Cepheid Inc.,

Others: Genomic Health Inc., Grifols Sa, Bayer Healthcare, Johnson & Johnson, Dalko Diagnostics, Sysmex Corporation, Illumina, Qiagen N.V., Novartis AG, Cepheid, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific among others.

Key Developments in the Market: Global Molecular Diagnostics Market

• In March 2018, According to the news posted in Globetech Media, Laboratories (Global healthcare diagnostics manufacturer) and Bosch Healthcare Solutions GmbH have partnered to launch molecular diagnostics platform which will be called as Vivalytic, It is an all-in-one fully automated solution that will help in molecular diagnostics.
• In June 2018, MDxHealth has announced worldwide licencing agreement with Koninklijke Philips N.V. for prognostic prostate cancer biomarker and for the rights to manufacture and market Philips. This test is basically based on technology which was jointly developed by Philips Research and The University of Glasgow. With the agreement MDxHealth will be able to prepare the launch of its InformMDx test for prostate cancer i.e. a tissue-based test with the utilization of PDE4D7 that can stratify patients conferring to their risk of disease progression and the development of secondary tumors.

Speak to Research Analyst for Regional Customization or Other Query: http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-molecular-diagnostics-market

Market Segmentation: Global Molecular Diagnostics Market

• The global molecular diagnostics market is segmented based on product & services , end user, application, technology and geographical segments.
• Based on product & service, the market is segmented into reagents & kits, instruments and services & software.
• On the basis of application, the market is classified into infectious diseases, oncology, genetic tests and other applications. The infectious diseases market is further sub segmented into hepatitis, HIV, CT/NG, HAIS, HPV, TB, influenza and other infectious diseases. The oncology market is further sub segmented into breast cancer, lung cancer, colorectal cancer, prostate cancer and other cancers.
• Based on technology, the market is segmented into polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), DNA sequencing & next-generation sequencing (NGS), in situ hybridization, DNA microarray and other technologies and other technologies.
• On the basis of end users, the market is segmented into hospitals & academic laboratories, reference laboratories and other end users.
• Based on geography , the market report covers data points for 28 countries across multiple geographies namely North America & South America, Europe, Asia-Pacific and, Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and Brazil among others.

Major Market Drivers and Restraints:

• High prevalence of infectious diseases and various types of cancers.
• Increasing awareness and acceptance of personalized medicine and companion diagnostics.
• Growth in the biomarker identification market and advancements in molecular techniques.
• Complex regulatory frameworks delaying the approval of new molecular diagnostic tests.

Get Full TOC of Report : https://databridgemarketresearch.com/toc/?dbmr=global-molecular-diagnostics-market

About Us

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing [email protected] . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research
Toll Free: +1-888-387-2818
Mail: [email protected]
http://databridgemarketresearch.com

Posted by Data Bridge Market Research on Tuesday January 08 2019, 8:19 AM EST. All trademarks acknowledged. Filed under Uncategorized. Comments and Trackbacks closed. Follow responses: RSS 2.0